Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 2.5 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis
CC(C)(C)C1=CC=CC=C1OC2=C(C=CC=N2)NC(=O)NC3=CC=C(C=C3)OC(F)(F)F,2100
CC1(CN(C2=CC=CC=C21)C3=CC=CC=C3NC(=O)NC4=CC=C(C=C4)OC(F)(F)F)C,8500
CN1CCN(C2=CC=CC=C21)C3=CC=CC=C3NC(=O)NC4=CC=C(C=C4)OC(F)(F)F,10000
CC(C)(C)CN1CCC2(CC1)CN(C3=CC=CC=C23)C4=CC=CC=C4NC(=O)NC5=CC=C(C=C5)OC(F)(F)F,670
CC1(CCN(C2=CC=CC=C21)C3=CC=CC=C3NC(=O)NC4=CC=C(C=C4)OC(F)(F)F)C,2200
C1COC2=CC=CC=C2N1C3=CC=CC=C3NC(=O)NC4=CC=C(C=C4)OC(F)(F)F,10000
CC(C)NC(=O)N1CCC2(CC1)CN(C3=CC=CC=C23)C4=CC=CC=C4NC(=O)NC5=CC=C(C=C5)OC(F)(F)F,10000
C1CN(CCC12CN(C3=CC=CC=C23)C4=CC=CC=C4NC(=O)NC5=CC=C(C=C5)OC(F)(F)F)CC6=CC=CC=C6,3300
CC1(CCN(C2=CC=CC=C21)C3=C(C=CC=N3)NC(=O)NC4=CC=C(C=C4)OC(F)(F)F)C,11100
C1CC2=CC=CC=C2N(C1)C3=CC=CC=C3NC(=O)NC4=CC=C(C=C4)OC(F)(F)F,10000
C1CC12CN(C3=CC=CC=C23)C4=CC=CC=C4NC(=O)NC5=CC=C(C=C5)OC(F)(F)F,10000
C1CC2(C1)CN(C3=CC=CC=C23)C4=CC=CC=C4NC(=O)NC5=CC=C(C=C5)OC(F)(F)F,4100
CC(C)CN1CCC2(CC1)CN(C3=CC=CC=C23)C4=CC=CC=C4NC(=O)NC5=CC=C(C=C5)OC(F)(F)F,2200
CC1(CN(C2=CC=CC=C21)C3=C(C=CC=N3)NC(=O)NC4=CC=C(C=C4)OC(F)(F)F)C,10000
CC1(CN(C2=CC=CC=C2O1)C3=CC=CC=C3NC(=O)NC4=CC=C(C=C4)OC(F)(F)F)C,10000
C1CCC2(C1)CN(C3=CC=CC=C23)C4=CC=CC=C4NC(=O)NC5=CC=C(C=C5)OC(F)(F)F,2400
CC(C)N1CCC2(CC1)CN(C3=CC=CC=C23)C4=CC=CC=C4NC(=O)NC5=CC=C(C=C5)OC(F)(F)F,4700
C1CCC2(CC1)CN(C3=CC=CC=C23)C4=CC=CC=C4NC(=O)NC5=CC=C(C=C5)OC(F)(F)F,2000
COCCN1CCC2(CC1)CN(C3=CC=CC=C23)C4=CC=CC=C4NC(=O)NC5=CC=C(C=C5)OC(F)(F)F,25400
COC(=O)N1CCC2(CC1)CN(C3=CC=CC=C23)C4=CC=CC=C4NC(=O)NC5=CC=C(C=C5)OC(F)(F)F,5800
CC1CCN(C2=CC=CC=C12)C3=CC=CC=C3NC(=O)NC4=CC=C(C=C4)OC(F)(F)F,10000
C1CN(CCC12CN(C3=CC=CC=C23)C4=CC=CC=C4NC(=O)NC5=CC=C(C=C5)OC(F)(F)F)C(=O)OCC6=CC=CC=C6,10000
